PCDHGCCRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。PCDHGC遺伝子サイレンサーは、PCDHGC CRISPR/Cas9ノックアウトプラスミドとPCDHGCDouble Nickaseプラスミドとして利用可能です。遺伝子活性化用のPCDHGCCRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
PCDHGC CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
PCDHGC4 CRISPR/Cas9 KOプラスミド (h) | sc-412652 | h | Gene Knockout | GFP | 0 | ||
PCDHGC4 HDRプラスミド (h) | sc-412652-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
PCDHGC4 Double Nickaseプラスミド (h) | sc-412652-NIC | h | Gene Knockout | Puromycin | 0 | ||
PCDHGC4 Double Nickaseプラスミド (h2) | sc-412652-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
Pcdhgc4 CRISPR/Cas9 KOプラスミド (m) | sc-430016 | m | Gene Knockout | GFP | 0 | ||
Pcdhgc4 HDRプラスミド (m) | sc-430016-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
Pcdhgc4 Double Nickaseプラスミド (m) | sc-430016-NIC | m | Gene Knockout | Puromycin | 0 | ||
Pcdhgc4 Double Nickaseプラスミド (m2) | sc-430016-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
PCDHGC5 CRISPR/Cas9 KOプラスミド (h) | sc-410038 | h | Gene Knockout | GFP | 0 | ||
PCDHGC5 HDRプラスミド (h) | sc-410038-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
PCDHGC5 Double Nickaseプラスミド (h) | sc-410038-NIC | h | Gene Knockout | Puromycin | 0 | ||
PCDHGC5 Double Nickaseプラスミド (h2) | sc-410038-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
Pcdhgc5 CRISPR/Cas9 KOプラスミド (m) | sc-430017 | m | Gene Knockout | GFP | 0 | ||
Pcdhgc5 HDRプラスミド (m) | sc-430017-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
Pcdhgc5 Double Nickaseプラスミド (m) | sc-430017-NIC | m | Gene Knockout | Puromycin | 0 | ||
Pcdhgc5 Double Nickaseプラスミド (m2) | sc-430017-NIC-2 | m | Gene Knockout | Puromycin | 0 |
PCDHGC CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
PCDHGC4 CRISPR Activationプラスミド (h) | sc-412652-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCDHGC4 CRISPR Activationプラスミド (h2) | sc-412652-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCDHGC4 Lentiviral Activation Particles (h) | sc-412652-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCDHGC4 Lentiviral Activation Particles (h2) | sc-412652-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Pcdhgc4 CRISPR Activationプラスミド (m) | sc-430016-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Pcdhgc4 CRISPR Activationプラスミド (m2) | sc-430016-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Pcdhgc4 Lentiviral Activation Particles (m) | sc-430016-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Pcdhgc4 Lentiviral Activation Particles (m2) | sc-430016-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCDHGC5 CRISPR Activationプラスミド (h) | sc-410038-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCDHGC5 CRISPR Activationプラスミド (h2) | sc-410038-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCDHGC5 Lentiviral Activation Particles (h) | sc-410038-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCDHGC5 Lentiviral Activation Particles (h2) | sc-410038-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Pcdhgc5 CRISPR Activationプラスミド (m) | sc-430017-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Pcdhgc5 CRISPR Activationプラスミド (m2) | sc-430017-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Pcdhgc5 Lentiviral Activation Particles (m) | sc-430017-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Pcdhgc5 Lentiviral Activation Particles (m2) | sc-430017-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |